Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years (terminated appraisal) TA1104 22 October 2025 22 October 2025 Clascoterone for treating ...
ASLA remains steadfast in our mission to advocate for landscape architects, advance climate resilience, and champion equitable, community-driven design. These principles are the foundation of our work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback